Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in
Status
ACTIVE
Global HQ
Tokyo, Japan
Countries of investment
  • Japan
Investment stages
  • Seed
  • Series A
Industries
  • Biotechnology
  • Health Tech
  • AI
About
Catalys Pacific is a premier life sciences investment firm dedicated to fostering innovation and growth within the global biotechnology sector. With a robust operational footprint in both Japan and the United States, Catalys Pacific harnesses its extensive network of industry experts and strategic partners to identify, develop, and invest in high-potential biotech companies. The firm is committed to advancing science and improving patient outcomes by supporting transformative solutions that address critical healthcare challenges. Through its expertise and strategic insights, Catalys Pacific aims to drive the next wave of breakthroughs in life sciences.
Min check size
$500K
Max check size
$10M
Fund size
NPS

Investment Thesis

They transform life sciences innovation by creating and investing in global biotech companies, focusing on transpacific partnerships betTheyen Japan and the United States.
Lead investor
Co Invest
Number of exits
Preferred contact method
Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp